The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss
Open accessAbstract
BACKGROUND: Many patients have uncontrolled blood pressure (BP) because they are not taking medications as prescribed. Providers may have difficulty accurately assessing adherence. Providers need to assess medication adherence to decide whether to address uncontrolled BP by improving adherence to the current prescribed regimen or by intensifying the BP treatment regimen by increasing doses or adding more medications. METHODS: We examined how provider assessments of adherence with antihypertensive medications compared with refill records, and how providers' assessments were associated with decisions to intensify medications for uncontrolled BP. We studied a cross-sectional cohort of 1169 veterans with diabetes presenting with BP ≥140/90 to 92 primary care providers at 9 Veterans Affairs (VA) facilities from February 2005 to March 2006. Using VA pharmacy records, we utilized a continuous multiple-interval measure of medication gaps (CMG) to assess the proportion of time in prior year that patient did not possess the prescribed medications; CMG ≥20% is considered clinically significant non-adherence. Providers answered post-visit Likert-scale questions regarding their assessment of patient adherence to BP medications. The BP regimen was considered intensified if medication was added or increased without stopping or decreasing another medication. RESULTS: 1064 patients were receiving antihypertensive medication regularly from the VA; the mean CMG was 11.3%. Adherence assessments by providers correlated poorly with refill history. 211 (20%) patients did not have BP medication available for ≥ 20% of days; providers characterized 79 (37%) of these 211 patients as having significant non-adherence, and intensified medications for 97 (46%). Providers intensified BP medications for 451 (42%) patients, similarly whether assessed by provider as having significant non-adherence (44%) or not (43%). CONCLUSIONS: Providers recognized non-adherence for less than half of patients whose pharmacy records indicated significant refill gaps, and often intensified BP medications even when suspected serious non-adherence. Making an objective measure of adherence such as the CMG available during visits may help providers recognize non-adherence to inform prescribing decisions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, clinician assessment of adherence is poor.105”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(2005) · PubMed · Cited by 7,011
The assessment of refill compliance using pharmacy records: Methods, validity, and applications
Steiner, J. F., & Prochazka, A. V. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00268-5 · Cited by 1,198
The Handbook of health behavior change
(2009) · Choice Reviews Online · doi:10.5860/choice.46-6233 · Cited by 616
Choo, P. W., Rand, C. S., Inui, T. S., Lee, M. T., Cain, E., Cordeiro-Breault, M., Canning, C. F., & Platt, R. G. (1999) · Medical Care · doi:10.1097/00005650-199909000-00002 · Cited by 546
Factors associated with medication refill adherence in cardiovascular-related diseases
Gazmararian, J. A., Kripalani, S. B., Miller, M. J., Echt, K. V., Ren, J., & Rask, K. J. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00591.x · Cited by 351
Measuring Adherence To Asthma Medication Regimens
Rand, C. S., & Wise, R. A. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/149.2_pt_2.s69 · Cited by 334
Lau, D. T., & Nau, D. P. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2149 · Cited by 317
The Handbook of health behavior change
(1991) · Choice Reviews Online · doi:10.5860/choice.28-5108 · Cited by 214
Kerr, E. A., Zikmund‐Fisher, B. J., Klamerus, M. L., Subramanian, U., Hogan, M. M., & Hofer, T. P. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00004 · Cited by 176
Self-citation
Research works printed but not linked: 1
- Hogan MM, Heisler M, Kerr EA, Hofer TP: Harnessing the power of VA data for identifying medication adherence for hypertension. 2007, In VA Health Services Research and Development Meeting. Crystal City: VA
Cited by
Sorted by citations
Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153
Adherence in Hypertension: A Review of Prevalence, Risk Factors, Impact, and Management
Burnier, M., & Egan, B. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313220 · Cited by 878
Choudhry, N. K., Kronish, I. M., Vongpatanasin, W., Ferdinand, K. C., Pavlik, V. N., Egan, B. M., Schoenthaler, A., Houston Miller, N., Hyman, D. J., & on behalf of the American Heart Association Council on Hypertension; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology (2022) · Hypertension · doi:10.1161/hyp.0000000000000203 · Cited by 349
Current Situation of Medication Adherence in Hypertension
Vrijens, B., Antoniou, S., Burnier, M., de la Sierra, A., & Volpe, M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00100 · Cited by 292
Lee, E. K. P., Poon, P. K.-M., Yip, B. H. K., Bo, Y., Zhu, M., Yu, C., Ngai, A. C. H., Wong, M. C. S., & Wong, S. Y. S. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026582 · Cited by 196
Hamrahian, S. M., Maarouf, O. H., & Fülöp, T. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s368784 · Cited by 212
Medication adherence in hypertension
Poulter, N. R., Borghi, C., Parati, G., Pathak, A., Toli, D., Williams, B., & Schmieder, R. E. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002294 · Cited by 178
The role of adherence in patients with chronic diseases
Burnier, M. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.07.008 · Cited by 162
Reese, P. P., Bloom, R. D., Trofe‐Clark, J., Mussell, A. S., Leidy, D., Levsky, S., Zhu, J., Yang, L., Wang, W., Troxel, A. B., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.10.017 · Cited by 139
Drug adherence in hypertension
Burnier, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.08.015 · Cited by 143
Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing
Lane, D., Lawson, A., Burns, A., Azizi, M., Burnier, M., Jones, D. J. L., Kably, B., Khunti, K., Kreutz, R., Patel, P., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17596 · Cited by 113
Resistant Hypertension: Novel Insights
Lamirault, G., Artifoni, M., Daniel, M., Barber‐Chamoux, N., & Nantes University Hospital Working Group on Hypertension (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666191011111402 · Cited by 96
How to Screen for Non-Adherence to Antihypertensive Therapy
Gupta, P., Patel, P., Horne, R., Buchanan, H., Williams, B., & Tomaszewski, M. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0697-7 · Cited by 84
Resistant Hypertension in People With CKD: A Review
Fay, K., & Cohen, D. L. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.04.017 · Cited by 80
Improving medication adherence in cardiovascular disease
Nelson, A. J., Pagidipati, N. J., & Bosworth, H. B. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00972-1 · Cited by 81
Dalli, L. L., Kilkenny, M. F., Arnet, I., Sanfilippo, F. M., Cummings, D. M., Kapral, M. K., Kim, J., Cameron, J., Yap, K. Y., Greenland, M., et al. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15391 · Cited by 73
Prescriber Continuity and Medication Adherence for Complex Patients
Hansen, R. A., Voils, C. I., Farley, J. F., Powers, B. J., Sanders, L. L., Sleath, B. L., & Maciejewski, M. L. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014563266 · Cited by 65
Encouraging adherence to long-term medication
Usherwood, T. P. (2017) · Australian Prescriber · doi:10.18773/austprescr.2017.050 · Cited by 65
Denig, P., Schuling, J., Haaijer‐Ruskamp, F. M., & Voorham, J. (2014) · BMJ · doi:10.1136/bmj.g5651 · Cited by 64
Zaugg, V., Korb-Savoldelli, V., Durieux, P., & Sabatier, B. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012042.pub2 · Cited by 61
Medication Non-adherence: a Major Cause of Resistant Hypertension
Hamrahian, S. M. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01400-3 · Cited by 61
Advances in Audio-Based Systems to Monitor Patient Adherence and Inhaler Drug Delivery
Taylor, T. E., Zigel, Y., Looze, C. D., Sulaiman, I., Costello, R. W., & Reilly, R. B. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.08.1162 · Cited by 46
Gosselink, M. E., van Buren, M. C., Kooiman, J., Groen, H., Ganzevoort, W., van Hamersvelt, H. W., van der Heijden, O. W. H., van de Wetering, J., & Lely, A. T. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.006 · Cited by 41
Wibowo, M. I. N. A., Yasin, N. M., Kristina, S. A., & Prabandari, Y. S. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s347079 · Cited by 40
Vittorio, J., Kosmach‐Park, B., King, L. Y., Fischer, R. T., Fredericks, E. M., Ng, V. L., Narang, A., Rasmussen, S. K., & Bucuvalas, J. C. (2022) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003560 · Cited by 34
Burnier, M., Prejbisz, A., Weber, T., Azizi, M., Cunha, V., Versmissen, J., Gupta, P., Václavík, J., Januszewicz, A., Persu, A., et al. (2021) · Blood Pressure · doi:10.1080/08037051.2021.1963209 · Cited by 33
Medication adherence and stroke/TIA risk in treated hypertensives: Results from the REGARDS study
Cummings, D. M., Letter, A. J., Howard, G., Howard, V. J., Safford, M. M., Prince, V., & Muntner, P. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2013.05.002 · Cited by 32
Yan, X. S., Mudiganti, S., Husby, H. M., Hudnut, A. G., Gbotoe, M., & Jones, J. B. (2022) · Scientific Reports · doi:10.1038/s41598-022-21916-8 · Cited by 29
Savarese, G., Lindberg, F., Cannata, A. N., Adamo, M., Ambrosio, G., Ameri, P., Anker, M. S., Bäck, M., Bayés‐Genís, A., Gal, T. B., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.70090 · Cited by 31
Detection of Nonadherence to Antihypertensive Treatment by Measurements of Serum Drug Concentrations
Bergland, O. U., Halvorsen, L. V., Søraas, C. L., Hjørnholm, U., Kjær, V. N., Rognstad, S., Brobak, K. M., Aune, A., Olsen, E., Fauchald, Y. M., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17514 · Cited by 29
den Ouden, H., Vos, R. C., & Rutten, G. E. H. M. (2017) · Health Expectations · doi:10.1111/hex.12563 · Cited by 28
Adherence to Treatment in Hypertension
Villalva, C. M., Álvarez, X. L. L., Mondelo, T. G., Fachado, A. A., & Cubiella, J. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_77 · Cited by 26
Lima, E. D. C., Osorio-de-Castro, C. G. S., Madruga, L. G. D. S. L., & Azeredo, T. B. (2017) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00136216 · Cited by 24
Lane, D., Patel, P., Khunti, K., & Gupta, P. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s162215 · Cited by 24
Heidari, P., Cross, W. M., Weller, C. D., Victoria Team, Nazarinia, M. A., & Crawford, K. (2019) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13660 · Cited by 24
Racial differences in statin adherence following hospital discharge for ischemic stroke
Albright, K. C., Zhao, H., Blackburn, J. L., Limdi, N. A., Beasley, T. M., Howard, G., Bittner, V., Howard, V. J., & Muntner, P. (2017) · Neurology · doi:10.1212/wnl.0000000000003910 · Cited by 21
Resistant Hypertension Updated Guidelines
Chernova, I., & Krishnan, N. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1209-6 · Cited by 21
Schulz, M., & Laufs, U. (2023) · Clinical Research in Cardiology · doi:10.1007/s00392-023-02230-3 · Cited by 20
Resistant Hypertension: Where are We Now and Where Do We Go from Here?
Pathan, M. K., & Cohen, D. L. (2020) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s223334 · Cited by 22
Medication adherence: measurement methods and approaches
Schnorrerova, P., Matalová, P., & Wawruch, M. (2024) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2024_40 · Cited by 21
Ipingbemi, A. E., Erhun, W. O., & Adisa, R. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06979-z · Cited by 20
Björk, J., Stenfors, T., Juth, N., & Gunnarsson, A. B. (2021) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2021.1935048 · Cited by 17
Medication Adherence in Hypertension
Blecker, S., Mann, D. M., Martinez, T. R., Belli, H. M., Zhao, Y., Ahmed, A., Fitchett, C., Wong, C., Bearnot, H. R., Voils, C. I., et al. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2025.2155 · Cited by 16
Improving adherence in chronic airways disease: are we doing it wrongly?
d’Ancona, G., & Weinman, J. A. (2021) · Breathe · doi:10.1183/20734735.0022-2021 · Cited by 15
Barreiras e facilitadores para adesão à farmacoterapia em doenças crônicas: uma revisão de escopo
Gonçalves, A. M. R. F., Campos, M. S. D. A., de Menezes, L. A., & Pereira, L. R. L. (2025) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232025302.02762023en · Cited by 14
Peeters, L. E. J., Bahmany, S., Dekker, T. J. A., Aliawi, A., van Domburg, B., Versmissen, J., & Koch, B. C. P. (2022) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000984 · Cited by 12
Ekbom, K., Strandqvist, A., Lajić, S., Hirschberg, A. L., Falhammar, H., & Nordenström, A. (2020) · Clinical Endocrinology · doi:10.1111/cen.14398 · Cited by 12
Assessing treatment adherence is crucial to determine adequacy of mineralocorticoid therapy
Pofi, R., Bonaventura, I., Duffy, J., Maunsell, Z., Shine, B. S. F., Isidori, A. M., & Tomlinson, J. (2023) · Endocrine Connections · doi:10.1530/ec-23-0059 · Cited by 12
Bhat, S., Derington, C. G., & Trinkley, K. E. (2020) · Applied Clinical Informatics · doi:10.1055/s-0040-1712467 · Cited by 11
Чазова, И. Е., Solntseva, T. D., Анатольевна, С. О., Ageev, F. T., Фофанова, Т. В., Bragina, A. E., & Trushina, O. I. (2024) · Systemic Hypertension · doi:10.38109/2075-082x-2024-2-5-15 · Cited by 10
Kably, B., Billaud, E. M., Boutouyrie, P., & Azizi, M. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01105-6 · Cited by 10
Sharma, J. R., Dludla, P. V., Dwivedi, G., & Johnson, R. (2023) · Global Heart · doi:10.5334/gh.1191 · Cited by 10
Controversies in Hypertension V: Resistant and Refractory Hypertension
Filippone, E. J., Naccarelli, G. V., & Foy, A. (2023) · The American Journal of Medicine · doi:10.1016/j.amjmed.2023.09.015 · Cited by 10
Optimizing drug adherence in hypertension: More than a mind game
Robberechts, T., Stoenoiu, M. S., Burnier, M., & Persu, A. (2024) · Kardiologia Polska · doi:10.33963/v.phj.99493 · Cited by 10
Medication adherence and non-adherence in arterial hypertension: a narrative review
Tomasino, C., & Tomasino, M. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001276 · Cited by 9
Jacobs, J. A., Derington, C. G., Zheutlin, A. R., King, J. B., Cohen, J. B., Bucheit, J. D., Kronish, I. M., Addo, D. K., Morisky, D. E., Greene, T., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.031574 · Cited by 9
Jacobs, C. M., Kunz, M., Mahfoud, F., Wagmann, L., & Meyer, M. R. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-04394-9 · Cited by 9
Goh, S. S. L., Lai, P. S. M., Liew, S.-M., Tan, K. M., Chung, W. W., & Chua, S. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242051 · Cited by 10
Voils, C. I., Gavin, K. L., Thorpe, C. T., Pabich, S., Reeve, B. B., Mian, G. J., Faacks, A., & Kronish, I. M. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s382885 · Cited by 8
Wibowo, M. I. N. A., Yasin, N. M., Kristina, S. A., & Prabandari, Y. S. (2021) · Malaysian Journal of Public Health Medicine · doi:10.37268/mjphm/vol.21/no.2/art.1048 · Cited by 8
Ratanawongsa, N., Karter, A. J., Quan, J., Parker, M. M., Handley, M. A., Sarkar, U., Schmittdiel, J. A., & Schillinger, D. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.8.688 · Cited by 7
The association of pre- and posthospital medication adherence in myocardial infarction patients
Doll, J. A., Hellkamp, A. S., Thomas, L. E., Fonarow, G. C., Peterson, E. D., & Wang, T. Y. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.11.004 · Cited by 7
Winters, A., Esse, T. W., Bhansali, A. H., Serna, O., Mhatre, S. K., & Sansgiry, S. S. (2016) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2016.22.3.305 · Cited by 7
Pinto, S., Kotschevar, C. M., Hunt, A. D., Middendorf, A. W., Robbins, C. B., Miller, E. E., & Gilder, D. V. (2022) · Pharmacy · doi:10.3390/pharmacy10060178 · Cited by 6
Measurements of Antihypertensive Medications in Blood and Urine
Gupta, P., Patel, P., & Tomaszewski, M. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-76593-8_4 · Cited by 6
Osman, H., Lane, D., Bernieh, D., Seidu, S., Patel, P., Khunti, K., Brunskill, N. J., Xu, G., & Gupta, P. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.09.033 · Cited by 6
Effect of Motivational Interviewing on Adherence to Treatment in Patients with Hypertension
Mirkarimi, K., Honarvar, M. R., Ariaie, M., Bordi, R., & Kamran, A. (2015) · Quarterly of Horizon of Medical Sciences · doi:10.18869/acadpub.hms.21.3.213 · Cited by 6
HIGHTON, P. J., Funnell, M. P., Lane, D., Vigneswara, V., Jenkins, S., Kacha, G., Gillies, C., Gupta, P., & Khunti, K. (2025) · Behavioral Medicine · doi:10.1080/08964289.2025.2503201 · Cited by 5
Gutiérrez, N. B., Galindo-García, C., Ramallo, H. R., & Sánchez‐Fidalgo, S. (2025) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2025.07.005 · Cited by 5
Complex breathlessness: assessment of treatment adherence and treatable traits
McLoughlin, R. F., & McDonald, V. M. (2022) · European Respiratory Society eBooks · doi:10.1183/2312508x.10013721 · Cited by 5
Adhikari, S., Stokes, T., Li, X., Zhao, Y., Fitchett, C., Ladino, N., Lawrence, S., Qian, M., Cho, Y., HAMO, C. E., et al. (2025) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaf162 · Cited by 4
Ratanawongsa, N., Quan, J., Handley, M. A., Sarkar, U., & Schillinger, D. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3071-4 · Cited by 4
Accuracy of Psychiatrists’ Assessment of Medication Adherence in an Outpatient Setting
Martin, K. B. (2020) · Cureus · doi:10.7759/cureus.11847 · Cited by 4
High non-adherence rates to secondary prevention by chemical adherence testing in patients with TIA
Lane, D., Beishon, L., Sharma, V., Salim, F., Sze, S., Timmins, M. A., Robinson, T. G., Eveson, D., Mistri, A. K., Patel, P., et al. (2022) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2022.106665 · Cited by 4
Gatwood, J. D., Hohmeier, K. C., Shuvo, S. A., Mikaiel, D., & Kovesdy, C. P. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.4.497 · Cited by 4
IAMM Group, Esposito, P. B., Rampino, T., Gregorini, M., Tinelli, C., SILVESTRI, A. D., Malberti, F., Coppo, R., & Canton, A. D. (2014) · Journal of Nephrology · doi:10.1007/s40620-014-0100-1 · Cited by 4
Adherence With Glaucoma Medications: Barriers to Success and Prospects for Improvement
Gale, M. J., Kinast, R. M., Sanchez, F. G., & Mansberger, S. L. (2021) · Current Ophthalmology Reports · doi:10.1007/s40135-021-00273-1 · Cited by 3
Васильевич, И. М., Emelyanov, I. V., & Конради, А. О. (2025) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2025-3192 · Cited by 3
Medical Measures in Hypertensives Considered Resistant
Elmula, F. E. M. F., Mariampillai, J. E., Heimark, S., Kjeldsen, S. E., & Burnier, M. (2023) · American Journal of Hypertension · doi:10.1093/ajh/hpad118 · Cited by 3
Medication adherence - the way to understand patients
Schnorrerova, P., Matalová, P., & Wawruch, M. (2024) · Klinická farmakologie a farmacie · doi:10.36290/far.2024.007 · Cited by 3
Adhikari, S., Mukhyopadhyay, A., Kolzoff, S., Li, X., Nadel, T., Fitchett, C., Chunara, R., Dodson, J. A., Kronish, I. M., & Blecker, S. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-076812 · Cited by 3
Zaugg, V., Korb‐Savoldelli, V., Durieux, P., & Sabatier, B. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012042 · Cited by 3
HIGHTON, P. J., Funnell, M. P., & Khunti, K. (2026) · Diabetes Therapy · doi:10.1007/s13300-026-01863-7 · Cited by 2
Васильевич, И. М., Emelyanov, I. V., Sviryaev, Y. V., & Конради, А. О. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6466 · Cited by 2
Abera, S. M., O’Donnell, C. I., Salahuddin, T., Prabhu, K., Simons, C. E., Ho, P. M., Waldo, S. W., & Doll, J. A. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s431183 · Cited by 2
Smith, I. D., England, B. R., Pagidipati, N. J., & Bosworth, H. B. (2025) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2025.2451141 · Cited by 2
Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement
Buffolo, F., Sconfienza, E., Burrello, J., Losano, I., Mengozzi, G., Priolo, G., Avataneo, V., D’Avolio, A., Veglio, F., Rabbia, F., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.668843 · Cited by 2
Kiliç, B., Biermans, M. C. J., Rutten, F. H., Deinum, J., Spiering, W., van der Wel, M. C., de Grauw, W. J. C., Bots, M. L., & Hollander, M. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.107062 · Cited by 2
Treatment of Work-Related Asthma: More Severe, Less Adherent, and Still Working
Pacheco, K. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.08.036 · Cited by 2
Scalable strategies for improving adherence in adults with hypertension—review
Egan, B. M. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001298 · Cited by 1
Peng, K. C., Almidani, L., Bradley, C., & Yohannan, J. (2026) · Ophthalmology Glaucoma · doi:10.1016/j.ogla.2026.02.005 · Cited by 1
Basu, S., Pangtey, R., Banerjee, B., & Kumar, S. (2021) · International Journal of Academic Medicine · doi:10.4103/ijam.ijam_155_20 · Cited by 1
Khiavi, F. F., Kalkhajeh, S. G., Gholizadeh, B., & Dindamal, B. (2023) · Health Research Policy and Systems · doi:10.1186/s12961-023-00984-w · Cited by 1
Jaffuel, D., Nogué, E., Roubille, F., Mallet, J., Bailly, S., Goupil, F., Thomas, A., Hervé, C., Masson, P., Bizieux‐Thaminy, A., et al. (2025) · ERJ Open Research · doi:10.1183/23120541.00081-2025 · Cited by 2
A Gap in Post-Stroke Blood Pressure Target Attainment at Entry to Cardiac Rehabilitation
Sawicki, C. P., OH, P. I., & Marzolini, S. (2020) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2020.231 · Cited by 2
Manolis, A. J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734299250.793571584 · Cited by 1
Rogers, K. A. (2015) · UA Campus Repository (The University of Arizona)
Exploring Factors Impacting Veterans' Hypertension Control
Liu, J. (2017) · Digital USD (University of San Diego) · doi:10.22371/07.2017.006
Use of Fixed-Dose Combinations in Hypertension and Cardiovascular Disease Prevention
Volpe, M., Tocci, G., & Gallo, G. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-76593-8_17
Hori, P. C. A. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2018.tde-07112018-093940
Metadata
- Authors
- Meddings, J., Kerr, E. A., Heisler, M., & Hofer, T. P.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Meddings, Jennifer
- Venue
- BMC Health Services Research
- Published
- 2012-08-21
- Volume
- 12
- Issue
- 1
- Pages
- 270-270
- ISSN
- 1472-6963 (ISSN-L)
- PMC
- PMC3570326
- OpenAlex
- W2140341066
- Cited by
- 117
- References
- 24
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 8 · 2023: 15 · 2022: 14 · 2021: 13 · 2020: 11 · 2019: 7 · 2018: 7 · 2017: 8 · 2016: 5 · 2015: 3 · 2014: 3 · 2013: 1
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Health Services Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Health Services Research and Development
- National Institutes of Health
- Agency for Healthcare Research and Quality (K08-HS1976701)
- National Institute of Diabetes and Digestive and Kidney Diseases (P60DK020572, P60 DK 20572, P30DK092926)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- medication adherence, uncontrolled hypertension, antihypertensive drugs, medication intensification, medication gaps, prescription refills
- MeSH terms
- Adult, Aged, Aged, 80 and over, Antihypertensive Agents, Cross-Sectional Studies, Decision Making, Humans, Hypertension, Middle Aged, Practice Patterns, Physicians', Physicians, Surveys and Questionnaires, Socioeconomic Factors, United States, Drug Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review